These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10846587)

  • 21. Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.
    Sanchez R; Portilla J; Gimeno A; Boix V; Llopis C; Sanchez-Paya J; Merino E; de la Sen ML; Muñoz C; Reus S; Plazas J
    J Infect; 2007 Feb; 54(2):159-66. PubMed ID: 16690132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up.
    Clevenbergh P; Durant J; Halfon P; del Giudice P; Mondain V; Montagne N; Schapiro JM; Boucher CA; Dellamonica P
    Antivir Ther; 2000 Mar; 5(1):65-70. PubMed ID: 10846595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of plasma human immunodeficiency virus type 1 RNA control after discontinuation of highly active antiretroviral therapy initiated at acute infection combined with structured treatment interruptions and immune-based therapies.
    Lafeuillade A; Poggi C; Hittinger G; Counillon E; Emilie D
    J Infect Dis; 2003 Nov; 188(10):1426-32. PubMed ID: 14624367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of early initiation of protease inhibitor-sparing antiretroviral regimen in human immunodeficiency virus-1 vertically infected infants.
    Van der Linden D; Hainaut M; Goetghebuer T; Haelterman E; Schmitz V; Maes P; Peltier A; Levy J
    Pediatr Infect Dis J; 2007 Apr; 26(4):359-61. PubMed ID: 17414406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superiority of protease inhibitors over nonnucleoside reverse-transcriptase inhibitors when highly active antiretroviral therapy is resumed after treatment interruption.
    Barreiro P; de Mendoza C; González-Lahoz J; Soriano V
    Clin Infect Dis; 2005 Sep; 41(6):897-900. PubMed ID: 16107992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
    Bani-Sadr F; Goderel I; Morand P; Payan C; Lunel F; Pol S; Perronne C; Carrat F; Cacoub P
    AIDS; 2007 Jul; 21(12):1645-8. PubMed ID: 17630563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients.
    Perez EE; Rose SL; Peyser B; Lamers SL; Burkhardt B; Dunn BM; Hutson AD; Sleasman JW; Goodenow MM
    J Infect Dis; 2001 Feb; 183(4):579-88. PubMed ID: 11170983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
    Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
    J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 DNA and RNA kinetics in primary HIV infection.
    Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
    J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Periodic multidrug therapy in a within-host virus model.
    Browne CJ; Pilyugin SS
    Bull Math Biol; 2012 Mar; 74(3):562-89. PubMed ID: 21822766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute clinical hepatitis in an HIV-seropositive hepatitis B carrier receiving protease inhibitor therapy.
    Mastroianni CM; Trinchieri V; Santopadre P; Lichtner M; Forcina G; D'Agostino C; Corpolongo A; Vullo V
    AIDS; 1998 Oct; 12(14):1939-40. PubMed ID: 9792403
    [No Abstract]   [Full Text] [Related]  

  • 33. Global stability of an HIV-1 model with distributed intracellular delays and a combination therapy.
    Liu S; Wang L
    Math Biosci Eng; 2010 Jul; 7(3):675-85. PubMed ID: 20578792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute human immunodeficiency virus type 1 infection.
    Kahn JO; Walker BD
    N Engl J Med; 1998 Jul; 339(1):33-9. PubMed ID: 9647878
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of significant viral load alterations of hepatitis B virus and hepatitis C virus during treatment with IL-2 and highly active antiretroviral therapy.
    Hengge UR; Roggendorf M; Goos M
    AIDS; 2000 Nov; 14(16):2617-9. PubMed ID: 11101079
    [No Abstract]   [Full Text] [Related]  

  • 36. Questions about results reported with potent antiretroviral therapy for human immunodeficiency virus type 1 infection.
    Papadopulos-Eleopulos E; Turner VF; Papadimitriou JM; Alfonso H; Page B; Causer D
    J Infect Dis; 2000 Apr; 181(4):1518-20. PubMed ID: 10762589
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiretroviral therapy in the year 2000.
    Tashima KT; Flanigan TP
    Infect Dis Clin North Am; 2000 Dec; 14(4):827-49. PubMed ID: 11144641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virology and immunology of acute HIV type 1 infection.
    Daar ES
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S229-34. PubMed ID: 9814948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of HIV-1 circular DNA as a surrogate marker for residual virus replication in patients with undetectable virus loads.
    Hauber I; Harrer T; Löw P; Schmitt M; Schwingel E; Hauber J
    AIDS; 2000 Nov; 14(16):2619-21. PubMed ID: 11101080
    [No Abstract]   [Full Text] [Related]  

  • 40. A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo.
    Markowitz M; Louie M; Hurley A; Sun E; Di Mascio M; Perelson AS; Ho DD
    J Virol; 2003 Apr; 77(8):5037-8. PubMed ID: 12663814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.